Blast Crisis
-
Subject Areas on Research
- A multicenter case-control study on predictive factors distinguishing childhood leukemia from juvenile rheumatoid arthritis.
- A multicenter phase I/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemia.
- Absence of somatic changes in p21 gene in non-Hodgkin's lymphoma and chronic myelogenous leukemia.
- Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy.
- Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.
- Blast phase in chronic myelogenous leukemia is skewed toward unusual blast types in patients treated with tyrosine kinase inhibitors: a comparative study of 67 cases.
- Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literature.
- Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases.
- Effect of thimerosal in leukemia, in leukemic cell lines, and on normal hematopoiesis.
- Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow.
- Hepatosplenic T-cell lymphoma with blastoid morphology in a patient with Crohn disease.
- Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia.
- Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration.
- Regulation of myeloid leukaemia by the cell-fate determinant Musashi.
- Simultaneous presence of major secondary chromosomal abnormalities in blast crisis of chronic myeloid leukemia.
- Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function.
- The role of protein phosphorylation in therapy resistance and disease progression in chronic myelogenous leukemia.
- β-Arrestin2 mediates the initiation and progression of myeloid leukemia.
-
Keywords of People
- Lagoo, Anand Shreeram, Professor of Pathology, Pathology